Method of fixating carbon dioxide to substituted oxazolidinones
US-12590074-B2 · Mar 31, 2026 · US
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D239/00 |
| Official title | Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings |
| Display label | Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings |
| Total patents | 38 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Pyrazolopyrimidine aryl ether inhibitors of JAK kinases and uses thereof
US-12528812-B2 · Jan 20, 2026 · US
Peg lipids and uses thereof
US-2025152518-A1 · May 15, 2025 · US
Bicyclic-fused heteroaryl or aryl compounds
US-12202836-B2 · Jan 21, 2025 · US
Method of fixating carbon dioxide to substituted oxazolidinones
US-2024400524-A1 · Dec 5, 2024 · US
PEG lipids and uses thereof
US-12151029-B2 · Nov 26, 2024 · US
Compounds for Modulating Epithelial 15-(S)-Lipoxygenase-2 and Methods of Use for Same
US-2024317691-A1 · Sep 26, 2024 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2023339960-A1 · Oct 26, 2023 · US
Bicyclic-fused heteroaryl or aryl compounds
US-11702424-B2 · Jul 18, 2023 · US
Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof
US-2022106322-A1 · Apr 7, 2022 · US
Use of erk5 inhibitors for treating gliomas in pediatric subjects
US-2022031710-A1 · Feb 3, 2022 · US
Use of TG02 for treating gliomas in pediatric subjects
US-11173160-B2 · Nov 16, 2021 · US
Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives
US-11026946-B2 · Jun 8, 2021 · US
Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives
US-10960007-B2 · Mar 30, 2021 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2020377511-A1 · Dec 3, 2020 · US
Use of tg02 for treating gliomas in pediatric subjects
US-2020368242-A1 · Nov 26, 2020 · US
Bicyclic-fused heteroaryl or aryl compounds
US-10793579-B2 · Oct 6, 2020 · US
Pharmacologically Active Alicyclic-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives
US-2020129515-A1 · Apr 30, 2020 · US
Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives
US-2020061068-A1 · Feb 27, 2020 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2019270751-A1 · Sep 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D239/00?
- CPC C07D239/00 is the Cooperative Patent Classification code for “Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings.”
- How many patents are filed under CPC C07D239/00 (Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings)?
- Our database includes 38 publications tagged with this CPC code.
- Is patent activity under CPC C07D239/00 growing?
- Publication counts under this code: 3 in 2024 vs 2 in 2025 (latest complete years).